Personalized phage therapy for hard-to-treat infections
Part of Digestive system, Genetic & congenital, Infections, Lungs & breathing, Skin clinical trials.
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a specific type of infection: an artificial joint or heart valve infection, persistent bacteria in the blood, a lung infection from cystic fibrosis or bronchiectasis, or a chronic sinus infection.
- All standard surgical and antibiotic treatments have already failed, or you have no other treatment options left.
- The bacteria causing your infection must be one that has a matching phage available in the trial's phage bank.
- You must agree to have your data collected in a patient registry for this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using phages (viruses that kill bacteria) for people with cystic fibrosis who have a chronic pseudomonas lung infection. It aims to see if adding phages to your usual care can help control the infection.
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
This study looks at how well phage therapy works for people with stubborn bacterial infections, like NTM. If your doctor is already considering phage therapy as part of your care, this trial may help track your response.
This study tests a new treatment that combines regular antibiotics with a special virus that attacks bacteria (called a phage) to fight lung infections that do not respond to standard antibiotics. It aims to see if this combination is safe and might help people with cystic fibrosis who have stubborn lung infections.
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
Hear when a new Chronic Rhinosinusitis (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.